中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 11
Nov.  2011
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2011  >  27(11): 1163-1166

Surgical therapy strategies of borderline resectable pancreatic cancer

  • Received Date: 2011-10-11
  • Published Date: 2011-11-20
    Abstract
  • The "borderline resectable" pancreatic cancer is a distinct subset which blurs the distinction between resectable and locally advanced disease.Patients with borderline resectable pancreatic cancer include those whose tumors have invaded either superior mesenteric vein, portal vein, common hepatic artery or superior mesenteric artery, but are still amenable to resection and reconstruction.The issues of surgical treatment for borderline resectable pancreatic cancer are as follows: the safety and efficacy of vascular resection and reconstruction, the boundary of extended lymphadenectomy, and the standardized examination of resection margin.A preoperative chemotherapy is recommended for these patients to maximize the potential for an R0 resection, despite the fact there is still no standard chemotherapy regimen or RCT research evidences.Under the current concept of multidisciplinary treatment for this disease, the clinical value of an R1 resection for the borderline resectable pancreatic cancer should be reconsidered.

     

    • FullText(HTML)
    • References(11)
  • [1] Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60 (5) : 277-300.
    [2]National Comprehensive Cancer Network (NCCN) Clinical Prac-tice Guidelines in Oncology for Pancreatic Adenocarcinoma V.2.2011.
    [3]Yekebas EF, Bogoevski D, Cataldegirmen G, et al.En blocvascular resection for locally advanced pancreatic malignan-cies infiltrating major blood vessels:perioperative outcomeand long-term survival in 136 patient[J].Ann Surg, 2008, 247 (2) :300-309.
    [4]Slidell MB, Chang DC, Cameron JL, et al.Impact of totallymph node count and lymph node ratio on staging and sur-vival after pancreatectomy for pancreatic adenocarcinoma:alarge, population-based analysis[J].Ann Surg Oncol, 2008, 15 (1) :165-174.
    [5]Raut CP, Tseng JF, Sun CC, et al.Impact of resection sta-tus on pattern of failure and survival after pancreaticoduode-nectomy for pancreatic adenocarcinoma[J].Ann Surg, 2007, 246 (1) :52-60.
    [6]Butturini G, Stocken DD, Wente MN, et al.Influence of re-section margins and treatment on survival in patients withpancreatic cancer:meta-analysis of randomized controlledtrials[J].Arch Surg, 2008, 143 (1) :75-83.
    [7]Doi R, Imamura M, Hosotani R, et al.Surgery versus radio-chemotherapy for resectable locally invasive pancreatic canc-er:Final results of a randomized multi-institutional trial[J].Surg Today, 2008, 38 (11) :1021-1028.
    [8] Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections[J]. Ann Surg Oncol, 2008, 15 (6) : 1651-1660.
    [9]Katz MHG, Pisters PWT, Evans DB, et al.Borderline resect-able pancreatic cancer:the importance of this emergingstage of disease[J].J Am Coll Surg, 2008, 206 (5) :833-848.
    [10] Glocher H, Brunner T, Grabenbauer G, et al. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy [J]. Eur J Surg Onco, 2008, 34 (7) : 756-764.
    [11]Gillen S, Schuster T, Meyer Zum Buschenfelde C, et al.Preop-erative/neoadjuvant therapy in pancreatic cancer:A systematicreview and meta-analysis of response and resection percenta-ges[J].PLoS Med, 2010, 7 (4) :e1000267.
    • Relative Articles

  • Relative Articles

    [1]Shengdeng CHEN, Zhiqiang MOU, Zhongyao CHEN, Jian WEN, Qiu LI. Predictive value of preoperative alkaline phosphatase to prealbumin ratio in prognosis and postoperative complications in patients with hepatocellular carcinoma after radical tumor resection[J]. Journal of Clinical Hepatology, 2023, 39(1): 118-127. doi: 10.3969/j.issn.1001-5256.2023.01.018
    [2]Branch of Hepatobiliary Diseases, Chinese Association of Chinese Medicine. The standards of traditional Chinese medicine syndrome differentiation for viral hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(10): 1839-1846. doi: 10.3969/j.issn.1001-5256.2017.10.002
    [3]Zhang Yi, Yu YongSheng, Tang ZhengHao, Jiang Hong, Xi Min, Zang GuoQing. Detection of serum retinol-binding protein, pre-albumin and albumin in patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2009, 25(6): 422-424.
    [4]Jin XueYuan, Lou Min, Zhao Ping, Long SuYun. Clinical significance of the serum neopterin detection in patients with chronic viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 90-91.
    [7]Luo KaiZhong, Su XianShi, Jiang YongFang. Measurement of serum level of insulin-like growth factor binding protein-3 in patients with viral hepatitis and its assessment on liver function[J]. Journal of Clinical Hepatology, 2006, 22(1): 24-26.
    [8]Tao Hu, Gao Tao, Xu Bin. Revaluate the clinical significance of serum transferrin changes in patients with hepatitis[J]. Journal of Clinical Hepatology, 2004, 20(3): 148-149.
    [10]Li ManNi, Zhang Fang, Su XianShi. Cloning of prealbumin cDNA and construction of the stable transfective cell line[J]. Journal of Clinical Hepatology, 2002, 18(4): 232-234.
    [11]Zhang Fang, Ceng XiaoBo, Su XianShi, Li ManNi. Significance of Assaying Serum Prealbumin in the patients with viral Hepatitis B[J]. Journal of Clinical Hepatology, 2001, 17(3): 163-164.
    [12]He DongGou, Chen BoMing, Lin YongPing. Research of T lymphocyte subtypes and the phagocytosis activity of macrophages in the patients with virul hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(1): 30-31.
    [13]Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 3.5 %FULLTEXT: 3.5 %META: 93.5 %META: 93.5 %PDF: 3.0 %PDF: 3.0 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 3.6 %其他: 3.6 %其他: 0.4 %其他: 0.4 %Central District: 0.7 %Central District: 0.7 %[]: 0.4 %[]: 0.4 %上海: 0.7 %上海: 0.7 %临汾: 0.4 %临汾: 0.4 %北京: 5.0 %北京: 5.0 %南宁: 0.4 %南宁: 0.4 %台州: 0.4 %台州: 0.4 %吉林: 0.4 %吉林: 0.4 %哥伦布: 0.7 %哥伦布: 0.7 %张家口: 3.6 %张家口: 3.6 %成都: 0.4 %成都: 0.4 %昆明: 0.4 %昆明: 0.4 %朝阳: 0.4 %朝阳: 0.4 %杭州: 0.4 %杭州: 0.4 %武汉: 0.4 %武汉: 0.4 %氹仔: 0.4 %氹仔: 0.4 %芒廷维尤: 38.0 %芒廷维尤: 38.0 %西宁: 39.4 %西宁: 39.4 %郑州: 0.4 %郑州: 0.4 %长春: 0.7 %长春: 0.7 %青岛: 2.9 %青岛: 2.9 %其他其他Central District[]上海临汾北京南宁台州吉林哥伦布张家口成都昆明朝阳杭州武汉氹仔芒廷维尤西宁郑州长春青岛

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (4526) PDF downloads(711) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2530]YesterdayPV[4969]TodayIP[1086]TodayPV[1758]Online[69]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return